KNSA (Kiniksa Pharmaceuticals International, plc) is set to announce its Q2'26 results on July 28, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).
For Q2'26, revenue estimate is 226.49 million USD with EPS (earnings per share) anticipated at 0.30 USD. Learn more details at .
Revenue & EPS values are provided in USD
| Q2'25Q3'25Q4'25Q1'26Q2'26 | |||||
| Revenue Reported156.80 M180.85 M202.13 M214.27 M— | Revenue Estimate146.48 M167.39 M200.81 M206.11 M226.49 M | Revenue Surprise+7.04%+8.05%+0.66%+3.96% | EPS Reported0.230.230.170.27 | EPS Estimate0.220.320.340.200.30 | EPS Surprise+4.44%-28.93%-50.70%+33.79% |